486 filings
Page 2 of 25
8-K
wpirza1jqccibv 8ztpk
9 May 24
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results
4:12pm
8-K
u62yhlk3shxxddydstj
8 May 24
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
5:00pm
144
d9o2gweq3
8 May 24
Notice of proposed sale of securities
4:19pm
ARS
fstv6rqnvthg
25 Apr 24
Annual report to shareholders
4:50pm
DEFA14A
3id33x
25 Apr 24
Additional proxy soliciting materials
4:48pm
4
0bv29r6a
22 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
5:23pm
4
okc83k
17 Apr 24
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:36pm
4
lp76yi1xxphm
17 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
4:30pm
144
93o0d7c99pm xdz9
15 Apr 24
Notice of proposed sale of securities
4:17pm
4
dfsrpd2y5
8 Apr 24
Crinetics Pharmaceuticals / Richard Scott Struthers ownership change
5:09pm
8-K
lejpc94g
4 Apr 24
Departure of Directors or Certain Officers
4:52pm
144
bxxjaids
4 Apr 24
Notice of proposed sale of securities
4:17pm
4
5dnlf2n0 8az
2 Apr 24
Crinetics Pharmaceuticals / Stephanie Okey ownership change
4:35pm
144
etk3gx3
28 Mar 24
Notice of proposed sale of securities
4:55pm
4
dic0 55lp05ng
26 Mar 24
Crinetics Pharmaceuticals / Jeff E. Knight ownership change
4:30pm
4
h43zy
22 Mar 24
Crinetics Pharmaceuticals / Dana Pizzuti ownership change
4:52pm
4
qqkdf
22 Mar 24
Crinetics Pharmaceuticals / Matthew K Fust ownership change
4:31pm
144
5rp0k9mh4432n6u1 ib
22 Mar 24
Notice of proposed sale of securities
2:34pm